Back
Supernus Pharmaceuticals Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
41
SUPN
Supernus Pharmaceuticals
Last Price:
34.66
Seasonality Move:
8.24%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SUPN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Supernus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.14 | Sell |
| 20-day SMA: | 33.47 | Buy |
| 50-day SMA: | 33.03 | Buy |
| 200-day SMA: | 30.49 | Buy |
| 8-day EMA: | 34.09 | Sell |
| 20-day EMA: | 33.57 | Buy |
| 50-day EMA: | 32.77 | Buy |
| 200-day EMA: | 30.99 | Buy |
Supernus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.54 | Buy |
| Relative Strength Index (14 RSI): | 56.13 | Buy |
| Chaikin Money Flow: | -431198 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Supernus Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Supernus Pharmaceuticals Stock
Is Supernus Pharmaceuticals Stock a Buy?
- Supernus Pharmaceuticals share price is 33.97 while SUPN 8-day simple moving average is 34.14, which is a Sell signal.
- The stock price of SUPN is 33.97 while Supernus Pharmaceuticals 20-day SMA is 33.47, which makes it a Buy.
- Supernus Pharmaceuticals 50-day simple moving average is 33.03 while SUPN share price is 33.97, making it a Buy technically.
- SUPN stock price is 33.97 and Supernus Pharmaceuticals 200-day simple moving average is 30.49, creating a Buy signal.
SUPN Technical Analysis vs Fundamental Analysis
Sell
41
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy or a Sell?
-
Supernus Pharmaceuticals stock is rated a Sell
The current Supernus Pharmaceuticals [SUPN] share price is $33.97. The Score for SUPN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Supernus Pharmaceuticals Stock Info
Market Cap:
1.87B
Price in USD:
33.97
Share Volume:
788.78K
Supernus Pharmaceuticals 52-Week Range
52-Week High:
35.56
52-Week Low:
23.05
Sell
41
Supernus Pharmaceuticals (SUPN)
is a Sell
Supernus Pharmaceuticals Share Price Forecast
-
What is the Supernus Pharmaceuticals stock price today?
The Supernus Pharmaceuticals stock price is 33.97 USD today. -
Will SUPN stock go up or go down?
Supernus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Supernus Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Supernus Pharmaceuticals is overvalued.
Is Supernus Pharmaceuticals Stock a Buy?
- Supernus Pharmaceuticals share price is 33.97 while SUPN 8-day exponential moving average is 34.09, which is a Sell signal.
- The stock price of SUPN is 33.97 while Supernus Pharmaceuticals 20-day EMA is 33.57, which makes it a Buy.
- Supernus Pharmaceuticals 50-day exponential moving average is 32.77 while SUPN share price is 33.97, making it a Buy technically.
- SUPN stock price is 33.97 and Supernus Pharmaceuticals 200-day simple moving average is 30.99, creating a Buy signal.
Fundamental Analysis of Supernus Pharmaceuticals
Is Supernus Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.18 per share.
Technical Analysis of Supernus Pharmaceuticals
Should I short Supernus Pharmaceuticals stock?
- SUPN Moving Average Covergence Divergence (MACD) indicator is 0.54, suggesting Supernus Pharmaceuticals is a Buy
- Supernus Pharmaceuticals Relative Strength Index (RSI) is 56.13, which suggest Supernus Pharmaceuticals is overbought
- The Bollinger Bands (25) for Supernus Pharmaceuticals is ( - ), which suggest Supernus Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Supernus Pharmaceuticals is ( - ), which suggest Supernus Pharmaceuticals is a Buy
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.